These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20350629)

  • 1. Cancer therapy with alpha-emitters labeled peptides.
    Dadachova E
    Semin Nucl Med; 2010 May; 40(3):204-8. PubMed ID: 20350629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-clinical experience with Re-188-RC-160, a radiolabeled somatostatin analog for use in peptide-targeted radiotherapy.
    Zamora PO; Bender H; Gulhke S; Marek MJ; Knapp FF; Rhodes BA; Biersack HJ
    Anticancer Res; 1997; 17(3B):1803-8. PubMed ID: 9179237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of cell inactivation by alpha-particle internal emitters.
    Humm JL; Chin LM
    Radiat Res; 1993 May; 134(2):143-50. PubMed ID: 8488249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
    Yao Z; Garmestani K; Wong KJ; Park LS; Dadachova E; Yordanov A; Waldmann TA; Eckelman WC; Paik CH; Carrasquillo JA
    J Nucl Med; 2001 Oct; 42(10):1538-44. PubMed ID: 11585870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new bivalent peptides for applications in the Affinity Enhancement System.
    Morandeau L; Benoist E; Loussouarn A; Ouadi A; Lesaec P; Mougin M; Faivre-Chauvet A; Le Boterff J; Chatal JF; Barbet J; Gestin JF
    Bioconjug Chem; 2005; 16(1):184-93. PubMed ID: 15656590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M; Hinni K; Tschumi S; Schulz S; Maecke HR
    J Nucl Med; 2005 Dec; 46(12):2097-103. PubMed ID: 16330576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
    Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
    J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
    Giblin MF; Veerendra B; Smith CJ
    In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.